Results 211 to 220 of about 105,256 (302)

Mediating Effect of Protein Intake on the Association Between Number of Remaining Teeth and Functional Decline

Gerodontology, EarlyView.
ABSTRACT Objective To examine whether protein intake mediates the association between the number of remaining teeth and functional decline in older Japanese adults. Introduction Tooth loss has been associated with reduced protein intake and functional decline in older adults.
Urara Taguchi, Sachiko Ono, Minami Sugimoto, Jun Aida, Hiroyuki Hikichi, Satoshi Sasaki, Ichiro Kawachi, Kazuto Hoshi   +7 more
wiley   +1 more source

A Mendelian randomization study reveals TNF-β as a potential protective factor against sarcopenia. [PDF]

Medicine (Baltimore)
Mei Z, Wan Y, Mao X, Qi W, Zhou G, Chen M, Li X, Pan H, Wang D.   +8 more
europepmc   +1 more source

Gerodontology Journal: A Scientometric Analysis of Research Trends, Citation and Evolution (2007–2025)

Gerodontology, EarlyView.
ABSTRACT Background Despite the longstanding contribution of Gerodontology to research on oral health and aging, its recent thematic development and patterns of scientific collaboration remain insufficiently characterized. This scientometric study analysed scientific production published in Gerodontology between 2007 and 2025 to characterize thematic ...
Jordana Rissi, Lara Sabrina Tissiani, Priscila Damazio Dondoni, Sinval Adalberto Rodrigues‐Junior   +3 more
wiley   +1 more source

Sarcopenia and Vitamin B12: Where Do We Stand? [PDF]

Muscles
Mavrou K, Ntelis N, Karakousis ND, Papagianni M.   +3 more
europepmc   +1 more source

Cisterna Chyli Dilation Is a Risk Factor for Liver Nodules and Hepatocellular Carcinoma in Fontan‐Associated Liver Disease: Pathophysiological Role of Lymphatic Dysfunction

Hepatology Research, EarlyView.
ABSTRACT Aim In Fontan‐associated liver disease (FALD), chronic congestion often confounds conventional fibrosis markers, complicating surveillance for hepatocellular carcinoma (HCC). Although lymphatic dysfunction is fundamental to Fontan physiology, its contribution to hepatocarcinogenesis remains unclear.
Koji Imoto, Masatake Tanaka, Takeshi Goya, Yuuki Azuma, Tomonobu Hioki, Yusuke Morita, Keisuke Sakaguchi, Nobuhiro Fujita, Takamori Kakino, Ayako Ishikita, Kenichiro Yamamura, Ichiro Sakamoto, Kousei Ishigami, Kohtaro Abe, Yoshihiro Ogawa   +14 more
wiley   +1 more source

Body weight-normalized resting metabolic rate and its associations with malnutrition and sarcopenia in hospitalized older adults: a cross-sectional study. [PDF]

Front Nutr
Jiang S, Zhao J, Chen P, Chen L, Chen W, Lin Z, Kang L, Li H, Zhao X, Wang Q.   +9 more
europepmc   +1 more source

Differential Cardiometabolic Risk Profiles of Lean and Obese Metabolic Dysfunction–Associated Steatotic Liver Disease: A Longitudinal Health Checkup Cohort Study

Hepatology Research, EarlyView.
Lean and Obese MASLD shared a common cardiometabolic basis, but the relative contributions of individual risk factors differed between phenotypes. Longitudinal changes in triglycerides and ALT were associated with incident MASLD in both phenotypes, reflecting evolving metabolic–hepatic vulnerability.
Hayato Kawamura, Kei Fujiwara, Ryo Sato, Takanori Suzuki, Kiyoto Narita, Kentaro Matsuura, Shunsuke Nojiri, Shigehiro Shiraki, Hiromi Kataoka   +8 more
wiley   +1 more source

Integrating Systemic Inflammation, Nutrition and Skeletal Muscle into a Composite Score (the HALP-Sarcopenia Combined Index) for Preoperative Risk Stratification of Lymph-Node Metastasis and Recurrence in Endometrial Carcinoma: A Single-Centre Retrospective Study. [PDF]

Int J Womens Health
Zhang Q, Guo D, Li D.
europepmc   +1 more source

Semaglutide in type 2 diabetes and chronic kidney disease in Australia: practical clinical considerations from a multidisciplinary panel

Internal Medicine Journal, EarlyView.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) are major causes of morbidity and mortality in people with type 2 diabetes (T2D). Contemporary CKD guidelines increasingly support incorporation of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) as an additional pillar of cardiorenal therapy alongside renin–angiotensin ...
Eugenia Pedagogos, Roger Chen, Adam Nelson, Sunil Badve, Roy Rasalam, Richard MacIsaac   +5 more
wiley   +1 more source